Do tardive dyskinesia and l-dopa induced dyskinesia share common genetic risk factors? An exploratory study

Lior Greenbaum, Stefano Goldwurm, Polina Zozulinsky, Tzuri Lifschytz, Oren S. Cohen, Gilad Yahalom, Roberto Cilia, Silvana Tesei, Rosanna Asselta, Rivka Inzelberg, Yoav Kohn, Sharon Hassin-Baer, Bernard Lerer

Research output: Contribution to journalArticle

Abstract

Tardive dyskinesia (TD) in schizophrenia patients treated with antipsychotic medications and l-dopa induced dyskinesia (LID) among Parkinson's disease (PD) affected individuals share similar clinical features. Both conditions are induced by chronic exposure to drugs that target dopaminergic receptors (antagonists in TD and agonists in LID) and cause pulsatile and nonphysiological stimulation of these receptors. We hypothesized that the two motor adverse effects partially share genetic risk factors such that certain genetic variants exert a pleiotropic effect, influencing susceptibility to TD as well as to LID. In this pilot study, we focused on 21 TD-associated SNPs, previously reported in TD genome-wide association studies or in candidate gene studies. By applying logistic regression and controlling for relevant clinical risk factors, we studied the association of the SNPs with LID vulnerability in two independent pharmacogenetic samples. We included a Jewish Israeli sample of 203 PD patients treated with l-dopa for a minimum of 3 years and evaluated the existence or absence of LID (LID+ = 128; LID- = 75). An Italian sample was composed of early LID developers (within the first 3 years of treatment, N = 187) contrasted with non-early LID developers (after 7 years or more of treatment, N = 203). None of the studied SNPs were significantly associated with LID susceptibility in the two samples. Therefore, we were unable to obtain proof of concept for our initial hypothesis of an overlapping contribution of genetic risk factors to TD and LID. Further studies in larger samples are required to reach definitive conclusions.

Original languageEnglish
Pages (from-to)380-388
Number of pages9
JournalJournal of Molecular Neuroscience
Volume51
Issue number2
DOIs
Publication statusPublished - Oct 2013

Keywords

  • Genetics
  • l-dopa induced dyskinesia
  • Parkinson's disease
  • Schizophrenia
  • Tardive dyskinesia

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Do tardive dyskinesia and l-dopa induced dyskinesia share common genetic risk factors? An exploratory study'. Together they form a unique fingerprint.

  • Cite this

    Greenbaum, L., Goldwurm, S., Zozulinsky, P., Lifschytz, T., Cohen, O. S., Yahalom, G., Cilia, R., Tesei, S., Asselta, R., Inzelberg, R., Kohn, Y., Hassin-Baer, S., & Lerer, B. (2013). Do tardive dyskinesia and l-dopa induced dyskinesia share common genetic risk factors? An exploratory study. Journal of Molecular Neuroscience, 51(2), 380-388. https://doi.org/10.1007/s12031-013-0020-x